Clin2
NCT06502873Possibly a fitRecruiting

Study of colon samples in IBD and healthy people

Inflammatory Bowel Disease (IBD)

Part of Digestive system clinical trials.

This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You have either Crohn's disease or ulcerative colitis that involves your colon or ileocolic area, and you are currently having a flare
  • Or you do not have IBD and have had a normal colonoscopy (no polyps, inflammation, or cancer)
  • You have not taken antibiotics in the last 3 months
  • You have not taken probiotic supplements in the last month
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05733702Recruiting
Study of Crohn’s and ulcerative colitis treatment changes

This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.

Luxembourg
NCT05733845Recruiting
Study of why some bowel inflammation treatments don’t work

This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.

Vandœuvre-lès-Nancy, CHRU de Nancy
NCT03809728Recruiting
Finding blood tests linked to outcomes in Crohn’s and colitis

This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.

Vandœuvre-lès-Nancy
NCT05456893Recruiting
Testing blood and stool markers in active ulcerative colitis treatments

This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.

Nancy, Lorraine
NCT00001184Recruiting
Studying the immune system in Crohn's and colitis

This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.

Bethesda, Maryland
NCT07686406Recruiting
IBD biomarker discovery study

This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.

Guangzhou, Guangdong

Hear when a new Inflammatory Bowel Disease (IBD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.